Company news

Memphasys Ltd news in 2026

Memphasys Ltd's news releases, calls and decks from 2026, newest first.

View company

Quarterly Activities/Appendix 4C Cash Flow Report

October 12, 2026

Memphasys receives A$3.5 million from Peters Investments

September 28, 2026

Potential Expedited FDA Pathway to US IVF Market

September 24, 2026

Memphasys Secures European Felix Agreement

September 17, 2026

Felix Registration Achieved in Turkey, Sales Commence

September 2, 2026

EUR526,500 Nordic Agreement Expands Felix European Footprint

August 31, 2026

Felix Early Thai FDA Approval, Commercial Launch Accelerates

August 27, 2026

Felix Registration Achieved in Vietnam and Cartridge Order

August 19, 2026

European Commercial Roll-out continues with Poland Agreement

August 4, 2026

Exclusive Thailand Commercialisation Agreement Secured

June 30, 2026

UK Market Entry & Acceleration of Commercial Expansion

June 24, 2026

Successful $1.2M Placement and Convertible Note Extended

June 17, 2026

Memphasys Executes Supply Agreement with Monash IVF Group

June 15, 2026

South-East Asian Commercialization Agreement Secured

May 31, 2026

ITL Orders 1000 Felix Cartridges Across MENA Markets

May 26, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

April 16, 2026

Investor Presentation - April 2026

April 7, 2026

MENA Orders Secured, Expanded & Operations Unaffected

March 19, 2026

Appendix 4D - Half-year Financial Report - 31 December 2025

February 27, 2026

Memphasys Secures TGA Approval for Felix System

February 8, 2026

Memphasys announces successful $800,000 Capital Raising

February 5, 2026

Trading Halt

February 3, 2026

Regulatory Submissions Lodged for Felix

February 2, 2026

Qatar's largest IVF Institution Places MENA Orders for Felix

February 1, 2026

Decks in 2026